Head-To-Head Survey: United American Healthcare (OTCMKTS:UAHC) and Humana (NYSE:HUM)

Humana (NYSE:HUM) and United American Healthcare (OTCMKTS:UAHC) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.

Analyst Ratings

This is a summary of current ratings for Humana and United American Healthcare, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	2	10	8	0	2.30
United American Healthcare	0	0	0	0	0.00

Humana currently has a consensus price target of $297.58, indicating a potential upside of 2.38%. Given Humana’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Humana is more favorable than United American Healthcare.

Risk & Volatility

Humana has a beta of 0.42, suggesting that its stock price is 58% less volatile than the S&P 500. Comparatively, United American Healthcare has a beta of -1.49, suggesting that its stock price is 249% less volatile than the S&P 500.

Institutional and Insider Ownership

92.4% of Humana shares are owned by institutional investors. 0.4% of Humana shares are owned by company insiders. Comparatively, 14.3% of United American Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Humana and United American Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Humana	1.28%	13.67%	4.85%
United American Healthcare	N/A	N/A	N/A

Earnings and Valuation

This table compares Humana and United American Healthcare”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$123.11 billion	0.28	$1.21 billion	$13.03	22.31
United American Healthcare	N/A	N/A	$240,000.00	N/A	N/A

Humana has higher revenue and earnings than United American Healthcare.

Summary

Humana beats United American Healthcare on 10 of the 11 factors compared between the two stocks.

About Humana

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

About United American Healthcare

United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.